Literature DB >> 21715503

Structural analysis of histo-blood group antigen binding specificity in a norovirus GII.4 epidemic variant: implications for epochal evolution.

Sreejesh Shanker1, Jae-Mun Choi, Banumathi Sankaran, Robert L Atmar, Mary K Estes, B V Venkataram Prasad.   

Abstract

Susceptibility to norovirus (NoV), a major pathogen of epidemic gastroenteritis, is associated with histo-blood group antigens (HBGAs), which are also cell attachment factors for this virus. GII.4 NoV strains are predominantly associated with worldwide NoV epidemics with a periodic emergence of new variants. The sequence variations in the surface-exposed P domain of the capsid protein resulting in differential HBGA binding patterns and antigenicity are suggested to drive GII.4 epochal evolution. To understand how temporal sequence variations affect the P domain structure and contribute to epochal evolution, we determined the P domain structure of a 2004 variant with ABH and secretor Lewis HBGAs and compared it with the previously determined structure of a 1996 variant. We show that temporal sequence variations do not affect the binding of monofucosyl ABH HBGAs but that they can modulate the binding strength of difucosyl Lewis HBGAs and thus could contribute to epochal evolution by the potentiated targeting of new variants to Lewis-positive, secretor-positive individuals. The temporal variations also result in significant differences in the electrostatic landscapes, likely reflecting antigenic variations. The proximity of some of these changes to the HBGA binding sites suggests the possibility of a coordinated interplay between antigenicity and HBGA binding in epochal evolution. From the observation that the regions involved in the formation of the HBGA binding sites can be conformationally flexible, we suggest a plausible mechanism for how norovirus disassociates from salivary mucin-linked HBGA before reassociating with HBGAs linked to intestinal epithelial cells during its passage through the gastrointestinal tract.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21715503      PMCID: PMC3165782          DOI: 10.1128/JVI.00848-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  41 in total

1.  Norwalk virus-like particle hemagglutination by binding to h histo-blood group antigens.

Authors:  Anne M Hutson; Robert L Atmar; Donald M Marcus; Mary K Estes
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

Review 2.  Norovirus and its histo-blood group antigen receptors: an answer to a historical puzzle.

Authors:  Ming Tan; Xi Jiang
Journal:  Trends Microbiol       Date:  2005-06       Impact factor: 17.079

3.  Genetic and phenotypic characterization of GII-4 noroviruses that circulated during 1987 to 2008.

Authors:  Yang Yang; Ming Xia; Ming Tan; Pengwei Huang; Weiming Zhong; Xiao Li Pang; Bonita E Lee; Jarek Meller; Tao Wang; Xi Jiang
Journal:  J Virol       Date:  2010-06-30       Impact factor: 5.103

4.  Norwalk virus infection and disease is associated with ABO histo-blood group type.

Authors:  Anne M Hutson; Robert L Atmar; David Y Graham; Mary K Estes
Journal:  J Infect Dis       Date:  2002-04-16       Impact factor: 5.226

5.  Structural basis for the receptor binding specificity of Norwalk virus.

Authors:  Weiming Bu; Aygun Mamedova; Ming Tan; Ming Xia; Xi Jiang; Rashmi S Hegde
Journal:  J Virol       Date:  2008-04-02       Impact factor: 5.103

6.  Differences in the biological phenotype of low-yielding (L) and high-yielding (H) variants of swine influenza virus A/NJ/11/76 are associated with their different receptor-binding activity.

Authors:  A S Gambaryan; M N Matrosovich; C A Bender; E D Kilbourne
Journal:  Virology       Date:  1998-08-01       Impact factor: 3.616

7.  Evolutionary dynamics of GII.4 noroviruses over a 34-year period.

Authors:  Karin Bok; Eugenio J Abente; Mauricio Realpe-Quintero; Tanaji Mitra; Stanislav V Sosnovtsev; Albert Z Kapikian; Kim Y Green
Journal:  J Virol       Date:  2009-09-16       Impact factor: 5.103

Review 8.  Scaling and assessment of data quality.

Authors:  Philip Evans
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2005-12-14

9.  Norwalk virus binds to histo-blood group antigens present on gastroduodenal epithelial cells of secretor individuals.

Authors:  Severine Marionneau; Nathalie Ruvoën; Beatrice Le Moullac-Vaidye; Monique Clement; Anne Cailleau-Thomas; Guillermo Ruiz-Palacois; Pengwei Huang; Xi Jiang; Jacques Le Pendu
Journal:  Gastroenterology       Date:  2002-06       Impact factor: 22.682

10.  Phaser crystallographic software.

Authors:  Airlie J McCoy; Ralf W Grosse-Kunstleve; Paul D Adams; Martyn D Winn; Laurent C Storoni; Randy J Read
Journal:  J Appl Crystallogr       Date:  2007-07-13       Impact factor: 3.304

View more
  82 in total

1.  The formation of P particle increased immunogenicity of norovirus P protein.

Authors:  Ming Tan; Xi Jiang
Journal:  Immunology       Date:  2012-05       Impact factor: 7.397

2.  Emergence of new pandemic GII.4 Sydney norovirus strain correlates with escape from herd immunity.

Authors:  Kari Debbink; Lisa C Lindesmith; Eric F Donaldson; Veronica Costantini; Martina Beltramello; Davide Corti; Jesica Swanstrom; Antonio Lanzavecchia; Jan Vinjé; Ralph S Baric
Journal:  J Infect Dis       Date:  2013-08-01       Impact factor: 5.226

3.  Genotypic and epidemiologic trends of norovirus outbreaks in the United States, 2009 to 2013.

Authors:  Everardo Vega; Leslie Barclay; Nicole Gregoricus; S Hannah Shirley; David Lee; Jan Vinjé
Journal:  J Clin Microbiol       Date:  2013-10-30       Impact factor: 5.948

4.  Mapping broadly reactive norovirus genogroup I and II monoclonal antibodies.

Authors:  Sue E Crawford; Nadim Ajami; Tracy Dewese Parker; Noritoshi Kitamoto; Katsuro Natori; Naokazu Takeda; Tomoyuki Tanaka; Baijun Kou; Robert L Atmar; Mary K Estes
Journal:  Clin Vaccine Immunol       Date:  2014-11-26

Review 5.  Norovirus.

Authors:  Elizabeth Robilotti; Stan Deresinski; Benjamin A Pinsky
Journal:  Clin Microbiol Rev       Date:  2015-01       Impact factor: 26.132

6.  Bioengineered Norovirus S60 Nanoparticles as a Multifunctional Vaccine Platform.

Authors:  Ming Xia; Pengwei Huang; Chen Sun; Ling Han; Frank S Vago; Kunpeng Li; Weiming Zhong; Wen Jiang; John S Klassen; Xi Jiang; Ming Tan
Journal:  ACS Nano       Date:  2018-09-25       Impact factor: 15.881

7.  The importance of intergenic recombination in norovirus GII.3 evolution.

Authors:  Jackie E Mahar; Karin Bok; Kim Y Green; Carl D Kirkwood
Journal:  J Virol       Date:  2013-01-16       Impact factor: 5.103

8.  Identifying carbohydrate ligands of a norovirus P particle using a catch and release electrospray ionization mass spectrometry assay.

Authors:  Ling Han; Elena N Kitova; Ming Tan; Xi Jiang; John S Klassen
Journal:  J Am Soc Mass Spectrom       Date:  2013-10-05       Impact factor: 3.109

9.  Recombination within the pandemic norovirus GII.4 lineage.

Authors:  John-Sebastian Eden; Mark M Tanaka; Maciej F Boni; William D Rawlinson; Peter A White
Journal:  J Virol       Date:  2013-03-27       Impact factor: 5.103

10.  Mutagenesis of zinc ligand residue Cys221 reveals plasticity in the IMP-1 metallo-β-lactamase active site.

Authors:  Lori B Horton; Sreejesh Shanker; Rose Mikulski; Nicholas G Brown; Kevin J Phillips; Ernest Lykissa; B V Venkataram Prasad; Timothy Palzkill
Journal:  Antimicrob Agents Chemother       Date:  2012-08-20       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.